Crossmark

Letter to the editor: Comment on “safety and effectiveness of remdesivir in COVID-19 patients with liver dysfunction: a retrospective cohort study”

Crossref DOI link: https://doi.org/10.1007/s40200-025-01819-x

Published Online: 2025-12-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Laique, Munazza https://orcid.org/0009-0002-0331-0357
Imran, Mahrukh https://orcid.org/0009-0001-1755-5198
Aiman, Umm e https://orcid.org/0009-0001-3982-095X
License Information

Text and Data Mining valid from 2025-12-18

Version of Record valid from 2025-12-18
More Information

Article History

Received: 2 November 2025

Accepted: 30 November 2025

First Online: 18 December 2025

Declarations

:

: The authors declare no competing interests.